Screener
Aquestive Therapeutics, Inc. AQST Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Aquestive Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Aquestive Therapeutics, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001398733-26-000042
FAQ
- What is Aquestive Therapeutics, Inc.'s asset turnover?
- Aquestive Therapeutics, Inc. (AQST) reported asset turnover of 0.5× in Q2 2026.
- How has Aquestive Therapeutics, Inc.'s asset turnover changed year-over-year?
- Aquestive Therapeutics, Inc.'s asset turnover increased by 14.7% year-over-year, from 0.4× to 0.5×.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s asset turnover?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s asset turnover has grown at a -12.1% compound annual growth rate (CAGR), from 0.6× to 0.3×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Aquestive Therapeutics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude